Sportathon – message from Ally McMurray, one of the founding members

 Dear All,
I’m undertaking a mammoth Sportathon for 3 charities over the months of August and September this year.
In completing this I’m hoping to raise £100,000 to split equally between Bloodwise, Bowel Cancer UK and the Brain Tumour Charity.
After raising over £30,000 running 30 half marathons in 30 days 8 years ago, I’ve decided to up the ante and set myself an even more difficult challenge to try and raise over 3 times this amount.
My challenge involves;
– Tennis for 12 hours (the longest match in history was 11 hours, over 3 days)
– Cycling from Lands End to John O’ Groats (10 days – 120 miles per day)
– Swimming 20 Kilometres (this will take around 10-11 hours)
– Running 30 half marathons in 30 days (each one must be under 2 hours)
These 3 charities which deal with cancers that have affected friends and family close to me.
I know that these charities don’t get as many donations as other cancer charities so wanted to try and raise a good chunk of money for them and also help raise awareness of the work that they do.
I’ve been training hard but not all the sports come naturally to me; I enjoy tennis, running and cycling, but I’m not a keen swimmer. The relentlessness of this is a real challenge for a bloke my age. 30 half marathons the first time back in 2011 was hard enough without having done all these other sports beforehand! My longest cycle is 65 miles, most I’ve ever played tennis is a couple of hours. I’ve never swam any sort of long distance – that will certainly be my biggest challenge.
 
If you can spare anything at all to sponsor me for the challenge I would be so grateful.

https://uk.virginmoneygiving.com/alloutally
 
Thanks so much guys, much appreciated
 
Ally
 

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article